医美行业洗牌:新势力崛起,老玩家如何破局?

21世纪经济报道
27 Feb

21世纪经济报道记者韩利明上海报道  在医美消费疲软、求美者需求变化等因素的共同作用下,医美上市企业各有忧喜。  日前,北交所“重组胶原蛋白第一股”锦波生物发布2024年年度业绩快报显示,报告期内实现营业收入14.47亿元,同比增长85.4%;归母净利润7.33亿元,同比增长144.65%;归母扣非净利润7.13亿元,同比增长149.56%。  锦波生物方面解释,营业收入增长主要系医疗器械及功能性...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10